Efficacy of the levonorgestrel intrauterine system in treating menorrhagia: Actualities and ambiguities

Journal of Family Planning and Reproductive Health

Volumn 28, Issue 2, 2002, Pages 99-100

  Ikomi, Amaju ^a   Pepra, Eric ^a  

^a BASILDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; PROGESTERONE DERIVATIVE;

ADENOMYOSIS; CONTRACEPTION; DEVICE REMOVAL; DRUG EFFICACY; ECHOGRAPHY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; PATIENT COUNSELING; PATIENT MONITORING; PATIENT SELECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UTERUS MYOMA; UTILIZATION REVIEW; ENDOMETRIOSIS; FEMALE; LEIOMYOMA; UTERUS CANCER; UTERUS DISEASE;

ENDOMETRIOSIS; FEMALE; HUMAN; INTRAUTERINE DEVICES, MEDICATED; LEIOMYOMA; LEVONORGESTREL; MENORRHAGIA; PROGESTATIONAL HORMONES, SYNTHETIC; UTERINE DISEASES; UTERINE NEOPLASMS; HUMANS; PROGESTERONE CONGENERS;

EID: 0036015731     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118902101196063     Document Type: Review

References (25)

1. Levonorgestrel-releasing intrauterine system
2. Levonorgestrel-releasing intrauterine system in the treatment of menorrhagia
3. Gynaecological aspects of the levonorgestrel-releasing intrauterine system
4. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia
5. Levonorgestrel-releasing intra-uterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding
6. Randomised controlled trial exists of levonorgestrel intrauterine system for menorrhagia
7. Health during prolonged use of levonorgestrel 20 mcg/d and the Copper Tcu 380 Ag intrauterine contraceptive devices: A multicenter study
8. Randomised trial comparing hysterectomy and transcervical endometrial resection: Effect on health related quality of life and costs two years after surgery
9. The levonorgestrel intrauterine system in the management of menorrhagia
10. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy with commentary by A Prentice]
11. Myornectomy
12. Uterine leiomyomata: Etiology, symptomatology and management
13. Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids
14. A randomised double-blind trial of gonadotrophin releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri
15. Protective effect of depotmedroxyprogesterone on surgically treated uterine leiomyomas: A multicentre case-control study
16. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD
17. Protective effect of depot-medroxyprogesterone on surgically treated uterine leiomyomas: A multicentre case-control study
18. Human leiomyoma cells: Binding and growth responses to epidermal growth factor, platelet-derived growth factor and insulin
19. The use of a levonorgestrel-intrauterine device in reduction of withdrawal bleeding in menopausal women with uterine fibroids
20. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient
21. Treatment of menorrhagia with the levonorgestrel intrauterine system: Can we learn from our failures?
22. Prolapse of pedunculated sub-mucous myoma following insertion of a levonorgestrel I.U.S: Two cautionary tales
23. Epidemiology of menstrual blood loss
24. Treatment of adenomvosis-associated menorrhagia with a levenorgestrel-releasing intrauterine device
25. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system